Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
New directions in the treatment of antidepressant-induced sexual dysfunction
Autore:
Rothschild, AJ;
Indirizzi:
Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01605 USA Univ Massachusetts Worcester MA USA 01605 ychiat, Worcester, MA 01605 USA
Titolo Testata:
CLINICAL THERAPEUTICS
, volume: 22, anno: 2000, supplemento:, A
pagine: A42 - A57
SICI:
0149-2918(2000)22:<A42:NDITTO>2.0.ZU;2-G
Fonte:
ISI
Lingua:
ENG
Soggetto:
SEROTONIN REUPTAKE INHIBITORS; INDUCED ANORGASMIA; DEPRESSED-PATIENTS; DOUBLE-BLIND; FLUOXETINE; SERTRALINE; DISORDER; BUPROPION; CYPROHEPTADINE; MULTICENTER;
Keywords:
sexual dysfunction; SSRIs; yohimbine; sildenafil citrate; buspirone; bupropion; nefazodone;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
49
Recensione:
Indirizzi per estratti:
Indirizzo: Rothschild, AJ Univ Massachusetts, Sch Med, Dept Psychiat, 361 Plantat St,Worcester, MA 01605 USA Univ Massachusetts 361 Plantat St Worcester MA USA01605 SA
Citazione:
A.J. Rothschild, "New directions in the treatment of antidepressant-induced sexual dysfunction", CLIN THER, 22, 2000, pp. A42-A57

Abstract

Objective: This article reviews options in the treatment of antidepressant-induced sexual dysfunction (SD). Background: With adoption of structured interviews concerning sexual function, researchers have become increasingly aware that a substantial proportion of patients experience untoward sexual side effects from their antidepressants. As many as half of patients treated with selective serotonin reuptake inhibitors report delayed orgasm (ejaculation), and virtually all patients treated with clomipramine experience anorgasmia. Treatments proven to beeffective include yohimbine, sildenafil citrate, buspirone, or other adjuncts, or a temporary drug holiday. SD is most effectively diagnosed and treated in the setting of an empathic physician-patient relationship, which includes frank discussions about sexuality. Conclusions: Although depressed patients do care about their sexual function, they may be reluctant, for fear of embarrassment, to report SD spontaneously to their physicians. SD is probably underreported and may result in covert noncompliance and attendant relapse into depression. Physicians thus need to assess sexual function during initial evaluation and throughout treatment. The importance of sexual function to sexually active patients with major depression should be weighed carefully when planning antidepressant therapy. A number of viable options exist to prevent or treat SD, including use of relatively new or novel antidepressants and appropriate adjunctive regimens.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/20 alle ore 19:22:55